Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
No intraday reading yet this session.
ALX Oncology Holdings Inc
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
94 institutional managers report a position in ALX Oncology Holdings Inc worth $218.0M between them, filed on form 13F for the quarter ending 2026-06-30. 14 of them hold 80% of it, the largest being RA Capital Management, LLC at 12.36%.
69 more managers in the register
14 managers hold 80% of the $218.0M institutional base. The other 80 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 79 days old and does not move with the price above it.
via RA Capital Management, LLC, Blackstone Group L.P., 5AM Venture Management, LLC +3 more · 12.36% of ALXO, 44.47% of ARTV
via RA Capital Management, LLC, TCG Crossover Management, LLC, Orbimed Advisors LLC +3 more · 12.36% of ALXO, 10.72% of MNPR
via RA Capital Management, LLC, TCG Crossover Management, LLC, Vivo Capital, LLC +5 more · 12.36% of ALXO, 7.36% of EDIT
via RA Capital Management, LLC, TCG Crossover Management, LLC, 5AM Venture Management, LLC +1 more · 12.36% of ALXO, 17.47% of TYRA
via RA Capital Management, LLC, TCG Crossover Management, LLC, ADAR1 Capital Management, LLC +2 more · 12.36% of ALXO, 13.22% of ZLAB
via RA Capital Management, LLC, Driehaus Capital Management LLC, ADAR1 Capital Management, LLC · 12.36% of ALXO, 14.37% of SEPN
Managers holding a meaningful stake in ALXO also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.
ALXO (ALX Oncology Holdings Inc) has 20 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Suppliers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move, and a bundle sits past the rings until you open it. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: JAZZ +1.06%, in the health bundle.